VCYT·Nasdaq·US
Veracyte
Veracyte develops and commercializes molecular diagnostic tests used to assess cancer and other diseases. The company sells genomic testing products primarily to physicians, hospitals, and laboratories, with a focus on improving diagnostic clarity and treatment decisions.
Recent Activity
Updated Oct 3, 2026
–Veracyte announced that eight studies focused on its Decipher test, including six oral presentations and two posters, will be presented at ASTRO 2026, highlighting Decipher's prognostic and predictive value in identifying patients' risk of disease progression.
Past updates are part of the Pro plan.
Thematic Position
Relationship Groups
Relationship details are part of the Pro plan.